Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $50.5 million.

  • Orthofix Medical's Accounts Payables rose 722.27% to $50.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.5 million, marking a year-over-year increase of 722.27%. This contributed to the annual value of $48.8 million for FY2024, which is 1637.16% down from last year.
  • Orthofix Medical's Accounts Payables amounted to $50.5 million in Q3 2025, which was up 722.27% from $45.1 million recorded in Q2 2025.
  • Orthofix Medical's 5-year Accounts Payables high stood at $58.4 million for Q4 2023, and its period low was $19.4 million during Q3 2021.
  • Its 5-year average for Accounts Payables is $39.8 million, with a median of $45.2 million in 2025.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 11145.37% in 2023, then tumbled by 2094.77% in 2025.
  • Orthofix Medical's Accounts Payables (Quarter) stood at $26.5 million in 2021, then grew by 4.3% to $27.6 million in 2022, then soared by 111.45% to $58.4 million in 2023, then fell by 16.37% to $48.8 million in 2024, then rose by 3.39% to $50.5 million in 2025.
  • Its last three reported values are $50.5 million in Q3 2025, $45.1 million for Q2 2025, and $45.2 million during Q1 2025.